1. Home
  2. ANIP

ANIP

ANI Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Founded: 2001 Country:
United States
United States
Employees: N/A City: BAUDETTE
Market Cap: 1.4B IPO Year: N/A
Target Price: $72.25 AVG Volume (30 days): 145.4K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.85 EPS Growth: N/A
52 Week Low/High: $36.99 - $70.81 Next Earning Date: 05-10-2024
Revenue: $486,816,000 Revenue Growth: 53.87%
Revenue Growth (this year): 12.16% Revenue Growth (next year): 7.56%

Share on Social Networks:

Stock Insider Trading Activity of ANI Pharmaceuticals Inc. (ANIP)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Apr 15 '24 Sell $66.33 7,414 $491,770.62 825,206 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Apr 15 '24 Sell $66.20 5,834 $386,210.80 819,372 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Apr 15 '24 Sell $65.40 9,520 $622,608.00 809,852 SEC Form 4
Cook Meredith ANIP SR. VP, GENERAL COUNSEL & SEC. Apr 12 '24 Sell $67.79 250 $16,947.50 59,731 SEC Form 4
Gassert Chad ANIP SVP - CORP. DEV. & STRATEGY Apr 1 '24 Sell $67.25 20,000 $1,345,000.00 253,226 SEC Form 4
Cook Meredith ANIP SR. VP, GENERAL COUNSEL & SEC. Mar 13 '24 Sell $66.54 250 $16,635.00 59,981 SEC Form 4
Gassert Chad ANIP SVP - CORP. DEV. & STRATEGY Mar 11 '24 Sell $65.81 20,000 $1,316,200.00 273,226 SEC Form 4
Marken James G. ANIP SVP OPS & PROD DEV Mar 7 '24 Sell $66.37 24,338 $1,615,313.06 124,492 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Mar 5 '24 Sell $65.35 10,093 $659,577.55 872,527 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Mar 5 '24 Sell $65.47 14,822 $970,396.34 857,705 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Mar 5 '24 Sell $66.35 15,085 $1,000,889.75 842,620 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Jan 16 '24 Sell $55.63 5,000 $278,150.00 927,620 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Jan 16 '24 Sell $55.11 10,000 $551,100.00 917,620 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Jan 16 '24 Sell $55.30 9,784 $541,055.20 907,836 SEC Form 4
Cook Meredith ANIP SR. VP, GENERAL COUNSEL & SEC. Dec 11 '23 Sell $49.21 250 $12,302.50 37,299 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Nov 17 '23 Sell $51.00 13,000 $663,000.00 982,620 SEC Form 4
Davis Krista ANIP SVP, CHIEF HR OFFICER Nov 15 '23 Sell $53.81 2,622 $141,089.82 32,587 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Nov 14 '23 Sell $53.17 22,905 $1,217,858.85 1,009,715 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Nov 14 '23 Sell $53.64 7,647 $410,185.08 1,002,068 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Nov 14 '23 Sell $51.66 6,448 $333,103.68 995,620 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Nov 14 '23 Sell $53.17 22,095 $1,174,791.15 1,010,525 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Nov 14 '23 Sell $53.64 7,647 $410,185.08 1,002,878 SEC Form 4
Shanmugam Muthusamy ANIP HEAD OF R&D, COO-NOVITIUM OPS Nov 14 '23 Sell $51.66 6,448 $333,103.68 996,430 SEC Form 4
Mutz Christopher ANIP HEAD OF RARE DISEASE Nov 10 '23 Sell $52.47 3,000 $157,410.00 63,607 SEC Form 4